Literature DB >> 4156027

Immunological disease induced by injecting F1 lymphoid cells into certain parental strains.

E Simpson, S O'Hopp, M Harrison, D Mosier, K Melief, H Cantor.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4156027      PMCID： PMC1445694     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  19 in total

1.  F1 hybrid animals: reactivity against recognition structures of parental strain lymphoid cells.

Authors:  H Ramseier; J Lindenmann
Journal:  Pathol Microbiol (Basel)       Date:  1969

2.  Rejection of skin allografts by irradiation chimeras: evidence for skin-specific transplantation barrier.

Authors:  E M Lance; E A Boyse; S Cooper; E A Carswell
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

3.  Cell mediated immunity induced in vitro.

Authors:  J R Wunderlich; T G Canty
Journal:  Nature       Date:  1970-10-03       Impact factor: 49.962

4.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

5.  Life-long tolerance and chimerism in parental mice induced with F 1 hybrid cells.

Authors:  V Silobrcić
Journal:  Eur J Immunol       Date:  1971-11       Impact factor: 5.532

6.  Leukemia virus activation in chronic allogeneic disease.

Authors:  M S Hirsch; P H Black; G S Tracy; S Leibowitz; R S Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

7.  Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder.

Authors:  R S Schwartz; L Beldotti
Journal:  Science       Date:  1965-09-24       Impact factor: 47.728

8.  Synergy among lymphoid cells mediating the graft-versus-host response. II. Synergy in graft-versus-host reactions produced by Balb-c lymphoid cells of differing anatomic origin.

Authors:  H Cantor; R Asofsky
Journal:  J Exp Med       Date:  1970-02       Impact factor: 14.307

9.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

10.  Chronic allogeneic disease. II. Development of lymphomas.

Authors:  M Y Armstrong; E Gleichmann; H Gleichmann; L Beldotti; J Andre-Schwartz; R S Schwartz
Journal:  J Exp Med       Date:  1970-09-01       Impact factor: 14.307
View more
  10 in total

1.  Transplantation tolerance correlates with high levels of T- and B-lymphocyte activity.

Authors:  A Bandeira; A Coutinho; C Carnaud; F Jacquemart; L Forni
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Tumor induction in host-versus-graft disease. I. Clinical and pathologic features.

Authors:  E A Cornelius
Journal:  Am J Pathol       Date:  1978-03       Impact factor: 4.307

Review 3.  Pathology, immunology and virology of the host versus graft syndrome.

Authors:  R C Hard; S S Cross
Journal:  Surv Immunol Res       Date:  1983

4.  Sequential changes in serum immunoglobulin levels in young RFM mice with host-versus-graft disease.

Authors:  R C Hard
Journal:  Immunology       Date:  1980-04       Impact factor: 7.397

5.  Hyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells.

Authors:  R C Hard
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

6.  Autoimmune disease and malignant lymphoma associated with host-versus-graft disease in mice.

Authors:  M Tateno; N Kondo; T Itoh; T Yoshiki
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

7.  Expression of murine leukemia viruses in RFM mice with host versus graft disease after perinatal inoculation of (T6 X RFM)F1 lymphohemopoietic cells.

Authors:  S S Cross; G Brede; H S Tucker; M Maloney; J L Montour; R C Hard
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

8.  Modulation of murine host-versus-graft disease by anti-CD3 monoclonal antibody.

Authors:  M Wissing; A Marchant; M Moser; V Flamand; O Leo; D Abramowicz; J Urbain; M Goldman
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

9.  Unfractionated spleen cells but not natural killer (NK) cells from RFM donors prevent the progression of host-versus-graft disease in murine RFM/(T6 x RFM)F1 chimeras.

Authors:  R C Hard; M R Patel; L M Keller; T J Linna
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

10.  Immunodeficiency in RFM/(T6xRFM)F1 mouse chimaeras with lethal host-versus-graft syndrome.

Authors:  R C Hard; J L Montour; B A Fuchs
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.